CT/NG
Chlamydia (Chlamydia trachomatis) is the most prevalent sexually transmitted bacterial infection (~3-4 million cases annually). Gonorrhea (Neisseria gonorrhoeae) is a bacterial infection that often co-exists with Chlamydia (~700,000 cases annually). Infection with either organism can cause pelvic inflammatory disease (PID), ectopic pregnancy, and infertility in women, and testicular and prostate infections, and sterility in men.
CytoGenes offers primer mixes and controls allowing laboratories to detect Chlamydia trachomatis and Neisseria gonorrhoeae by quantitative PCR. Results are qualitative, indicating the presence or absence of each of the target organisms. An internal control primer set is available to verify the quality of the DNA extraction process.
|
References
|
Additional Product Information
|
|
Jaton K, Bille J, Greub G. A novel real-time PCR to detect Chlamydia trachomatis in first-void urine or genital swabs. J Med Microbiol. 2006 Dec;55(Pt 12):1667-74. PubMed PMID: 17108270.
Whiley DM, Limnios A, Moon NJ, Gehrig N, Goire N, Hogan T, Lam A, Jacob K, Lambert SB, Nissen MD, Sloots TP. False-negative results using Neisseria gonorrhoeae porA pseudogene PCR – a clinical gonococcal isolate with an N. meningitidis porA sequence, Australia, March 2011. Euro Surveill. 2011 May 26;16(21). pii: 19874. PubMed PMID: 21632019.
|
CT/NG Primer Mixes Product Data Sheet CT/NG Controls Product Data Sheet |